Trial intelligence / Profile preview

Rectal misoprostol before abdominal myomectomy to reduce blood loss

IRCT20080826001096N5Phase 3Completed

Sponsor
Guilan University of Medical Sciences
Start
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Fibromyoma (LM) comparing Misoprostol rectal preoperative arm with Placebo preoperative arm (2 arms). Primary endpoint: Volume of hemorrhage during and after myomectomy. Started Apr 2018; status: completed.

02

Drugs

misoprostol
03

Conditions

Fibromyoma (LM)

Beyond the preview

Go deeper on IRCT20080826001096N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20080826001096N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call